TAYSHA GENE THERAPIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.57 USD | -0.39% |
|
+7.53% | +45.20% |
Chart calendar Taysha Gene Therapies, Inc.
4ae59e6b41ddc0c75c1c9d64ad.GV1y37rX4EoFFP3KS-ZDG-FKYCzNzMcItPSoBCo_66s.ew0zmsKQkTp8ILfnfYEnfrMoIkX0r_I_gK7fM0ZHg55oDDnp27GFenJwuA~6338cec1145465206a6fe0b3096fd11c
Upcoming events on Taysha Gene Therapies, Inc.
Past events on Taysha Gene Therapies, Inc.
| 19/03/2024 20:30 | Q4 2023 Earnings Call |
| 19/03/2024 20:01 | Q4 2023 Earnings Release |
| 25/01/2024 12:05 | British Paediatric Neurology Association Conference - Poster No: 056 |
| 15/11/2023 20:00 | Extraordinary Shareholders Meeting |
| 14/11/2023 21:30 | Q3 2023 Earnings Call |
| 14/11/2023 21:08 | Q3 2023 Earnings Release |
| 26/10/2023 19:30 | European Society of Gene and Cell Therapy Conference - Poster No.-P435 |
| 26/10/2023 18:30 | European Society of Gene and Cell Therapy Conference - Poster No. - P302 |
| 25/10/2023 17:15 | European Society of Gene and Cell Therapy Conference - Poster No. - P302 |
| 25/10/2023 16:00 | European Society of Gene and Cell Therapy Conference - Poster No.-P435 |
| 14/08/2023 13:30 | Q2 2023 Earnings Call |
| 14/08/2023 12:02 | Q2 2023 Earnings Release |
| 28/06/2023 15:00 | R&D Day |
| 22/06/2023 16:00 | Annual General Meeting |
| 19/05/2023 20:00 | American Society of Gene Cell Therapy Meeting - Poster Number: 1365 |
| 11/05/2023 21:30 | Q1 2023 Earnings Call |
| 11/05/2023 21:01 | Q1 2023 Earnings Release |
| 28/03/2023 21:30 | Q4 2022 Earnings Call |
| 28/03/2023 21:01 | Q4 2022 Earnings Release |
| 31/01/2023 21:30 | TSHA-120 GAN Program Update Call |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 2,50 8,18 -69.42% | 15,5 14,5 6.72% | 9,22 |
|
EBITDA Million USD | Released Forecast Spread | -43,0 -35,0 -22.73% | -173 -160 -8.2% | -125 -131 4.33% | -71,1 -66,7 -6.55% | -67,5 |
|
EBIT Million USD | Released Forecast Spread | -43,0 -36,3 -18.49% | -173 -171 -1.56% | -162 -128 -27.33% | -72,4 -73,5 1.4% | -74,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -60,0 -48,6 -23.48% | -175 -171 -1.89% | -166 -149 -11.35% | -112 -177 37.13% | -77,9 |
|
Net income Million USD | Released Forecast Spread | -60,0 -53,9 -11.44% | -175 -171 -1.95% | -166 -149 -11.35% | -112 -178 37.2% | -77,9 |
|
EPS USD | Released Forecast Spread | -3,40 -3,15 -8.11% | -4,64 -4,52 -2.64% | -3,78 -3,22 -17.42% | -0,96 -1,43 33.04% | -0,41 |
| Announcement Date | 03/03/21 | 31/03/22 | 28/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 2,50 9,00 -72.2% | 4,71 1,13 318.31% | 2,40 1,86 28.57% | 4,75 2,10 126.11% | 3,60 2,65 35.77% | 2,31 | 2,31 | 2,30 | 2,32 | 3,10 |
|
EBIT Million USD | Released Forecast Spread | -49,7 -47,9 -3.74% | -49,3 -41,1 -19.86% | -33,0 -39,9 17.24% | -25,1 -32,6 23.15% | -55,1 -21,4 -157.76% | -16,6 -21,7 23.84% | -23,4 -20,6 -13.37% | -15,6 -22,0 28.95% | -16,2 -17,4 6.4% | -18,5 | -19,2 | -19,7 | -19,5 | -22,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -50,4 -46,6 -8.08% | -50,1 -40,5 -23.74% | -33,9 -39,4 14.12% | -26,3 -32,8 19.75% | -55,7 -21,8 -155.44% | -17,6 -22,7 22.35% | -24,6 -21,9 -12.16% | -117 -23,3 -402.05% | 47,7 -21,7 320.2% | -19,3 | -19,8 | -20,2 | -20,2 | -22,4 |
|
Net income Million USD | Released Forecast Spread | -50,4 -46,6 -8.19% | -50,1 -40,3 -24.22% | -33,9 -39,4 14.12% | -26,3 -32,8 19.75% | -55,7 -21,8 -155.44% | -17,6 -22,7 22.35% | -24,6 -21,9 -12.16% | -117 -23,3 -402.05% | 47,7 -21,7 320.2% | -19,3 | -19,8 | -20,2 | -20,2 | -22,4 |
|
EPS USD | Released Forecast Spread | -1,32 -1,22 -8.61% | -1,31 -1,07 -22.68% | -0,84 -0,97 13.68% | -0,64 -0,79 19.46% | -0,99 -0,30 -228.9% | -0,28 -0,35 20.57% | -0,38 -0,31 -21.12% | -0,93 -0,17 -435.25% | 0,92 -0,11 908.79% | -0,11 | -0,12 | -0,12 | -0,11 | -0,11 |
| Announcement Date | 31/03/22 | 16/05/22 | 11/08/22 | 08/11/22 | 28/03/23 | 11/05/23 | 14/08/23 | 14/11/23 | 19/03/24 | - | - | - | - | - |
More events
Past sector events for Taysha Gene Therapies, Inc.
| 02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TSHA Stock
- Calendar Taysha Gene Therapies, Inc.
